Related Experiment Videos

[Nosocomial respiratory infection caused by Pseudomonas cepacia in immunocompromised hosts]

J Fujita1, K Negayama, K Takigawa

  • 1First Department of Internal Medicine, Kagawa Medical School.

Nihon Kyobu Shikkan Gakkai Zasshi
|July 1, 1992
PubMed

Insights

Pseudomonas cepacia, a bacterium, was found in hospitalized patients with severe illnesses, often preceding pneumonia. Minocycline showed high effectiveness against this organism.

Area of Science:

  • Clinical Microbiology
  • Infectious Diseases
  • Hospital Epidemiology

Background:

  • Pseudomonas cepacia is a gram-negative bacterium.
  • This organism can cause nosocomial infections, particularly respiratory infections.
  • Patients with severe underlying diseases are at higher risk for colonization and infection.

Purpose of the Study:

  • To investigate the incidence and clinical significance of Pseudomonas cepacia detection in hospitalized patients.
  • To identify risk factors and associated conditions, such as pneumonia.
  • To evaluate the antibiotic susceptibility of Pseudomonas cepacia.

Main Methods:

  • Retrospective analysis of 22 patients from whom Pseudomonas cepacia was detected in sputum, throat swab, or throat washing.
  • Review of patient medical records, including primary diagnoses and antibiotic treatments.
  • Clinical assessment of pneumonia development and antibiotic susceptibility testing.

Main Results:

  • Pseudomonas cepacia was detected in 22 inpatients between January and December 1990.
  • The majority of patients had underlying conditions like leukemia or malignant lymphoma.
  • Twelve patients developed pneumonia, with the organism often detected prior to pneumonia onset. Minocycline demonstrated 100% effectiveness against the isolated strains.

Conclusions:

  • Pseudomonas cepacia colonization and nosocomial respiratory infection are potential risks for severely ill patients.
  • Awareness of this pathogen is crucial for timely diagnosis and management.
  • Minocycline appears to be a highly effective antibiotic against Pseudomonas cepacia.

Related Concept Videos